New PLoS Clinical Trials Paper:
Impact of Malaria Prophylaxis on Learning in Children

August 22, 2006

Dear Colleague,

Wed like to draw your attention to a research article published online in PLoS Clinical Trials, entitled "Long-term impact of malaria chemoprophylaxis on cognitive abilities and educational attainment: Follow-up of a controlled trial" by Matthew Jukes and colleagues.

Please feel free to read, share, print, and use this article any way you wish, all at no charge thanks to open access publishing.

The Study

The burden of disease and death from malaria is well documented, but little is known about the impact of malaria on the mental development of children and their ability to learn. Jukes and colleagues examined a cohort of children who had taken part in a malaria prevention trial 14 years earlier, and found some evidence of a long-term effect of malaria prevention on cognitive function and educational attainment.

Why Publish in PLoS Clinical Trials?

"Institutions in low-income countries often cannot afford to read the research papers in which they participate. PLoS's open-access policy ensures that findings in international health and education are quickly communicated to those for whom they have most relevance and are readily accessible to everyone else"

Matthew Jukes, Partnership for Child Development, Imperial College London

>>> More reasons to publish in PLoS Clinical Trials

PLoS Clinical Trials

PLoS Clinical Trials is an international peer-reviewed, open-access journal that publishes results of randomized trials from all medical and public health disciplines. The journal’s aim is to increase the breadth of clinical trials reporting and thus ensure that all trials on human participants are reported in the peer-reviewed literature and accessible to all.

If you find this new article of interest, you can:

  • Sign up for regular email table of contents alerts. We will send the first 50 to respond a free PLoS laser pointer (one per individual) just to say thanks for joining us.
  • Read additional articles online.
  • Submit your next great paper to PLoS Clinical Trials.
  • Forward this email to colleagues—all PLoS Clinical Trials papers are free to everyone.

With best regards,

Emma Veitch, PhD

Publications Manager, PLoS Clinical Trials